During a joint workshop on Monday, officials from the US Food and Drug Administration (FDA) and National Institutes of Health (NIH) outlined efforts to reduce animal testing. FDA Commissioner Marty ...

The US Food and Drug Administration (FDA) has proposed guidance to reduce the need for animal testing in the development of oncology drugs as part of its broader efforts to reduce animal testing in ...

News, features, and commentary about cancer-related issues ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away from animal testing, improving scientific outcomes and marking a victory ...

When the US Food and Drug Administration announced it would begin phasing out animal studies in April, many in the scientific community were stunned. For decades, animal testing has been considered a ...

The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs. “This draft guidance not only ...

Following the United States, Europe has also announced a roadmap to phase out animal testing. The global momentum to reduce ...

The FDA's announcement in April that it will phase out animal testing in clinical trials came as a victory for animal rights activists but garnered mixed reactions among health researchers. The agency ...